南美和中美洲疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗(仿制药、原研药、疫苗及其他)、给药途径(口服和肠外给药)和分销渠道(直接招标、医院药房、零售药房、网上药房及其他)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 75    |    Report Code: TIPRE00025039    |    Category: Life Sciences

South & Central America Malaria Treatment Market
2022 年,南美和中美疟疾治疗市场价值为 5968 万美元,预计到 2030 年将达到 2.4733 亿美元;预计 2022 年至 2030 年的复合年增长率为 19.4%。

市场参与者不断增长的战略举措推动南美和中美疟疾治疗市场的发展

疟疾治疗市场的一些主要参与者越来越注重采用各种战略,如产品创新、发布和批准;研发投资;以及并购,以保持竞争力。下面提到了其中一些举措:



2023 年,R21/Matrix-M 疟疾疫苗被列入世卫组织的预审疫苗名单。根据疟疾政策咨询小组和世卫组织免疫战略咨询专家组 (SAGE) 的建议,世卫组织建议于 2023 年 10 月推出该疫苗,以预防儿童疟疾。预认证是联合国儿童基金会购买疫苗的必要条件,也是全球疫苗免疫联盟 (Gavi) 为其部署提供资金支持的必要条件,这意味着更多的儿童将有机会获得疫苗,而疫苗是抗击疟疾的关键工具。



2021 年 12 月,Zydus Cadila 宣布计划与抗疟药物研发基金会合作开发其抗疟药物 ZY19489,并获得美国 FDA 批准。据该公司介绍,ZY19489 的 I 期试验表明,该药物半衰期较长,并且有可能单剂量治愈疟疾。在另一项疟疾挑战试验中,单次口服 ZY19489 后显示出强大的抗疟活性。- 全球



2021 年 1 月,葛兰素史克 (GSK)、PATH 和 Bharat Biotech (BBIL) 宣布签署了疟疾疫苗 RTS,S/AS01E 的产品转让协议。该协议包括将疫苗的RTS,S抗原部分的制造转让给BBIL,并授予与疟疾疫苗相关的所有权利的许可。GSK保留疫苗佐剂(AS01E)的生产并将其供应给BBIL。

因此,市场参与者的上述战略举措预计将在未来几年为疟疾治疗市场提供增长机会。

南美和中美洲疟疾治疗市场概况

疟疾一直是巴西的主要公共卫生问题。根据NCBI的一篇文章,在巴西,疟疾是由三种疟原虫引起的,即间日疟原虫(占已登记病例的83.7%)、恶性疟原虫(占16.3%)和三日疟原虫(记录了一小部分病例)。

巴西政府启动了国家疟疾消除计划,旨在到 2025 年将当地疟疾病例数减少到 68,000 例以下,到 2030 年消除相关死亡,到 2035 年在该国根除疟疾。巴西拥有亚马逊雨林,记录了大多数疟疾病例。巴西约 99.9% 的传播发生在亚马逊地区,80% 发生在 33 个城市。根据世卫组织 2020 年世界疟疾报告,巴西近年来已登记约 200,000 例病例;其中约 99% 的病例集中在合法亚马逊地区。巴西政府正在投资治疗开发、害虫控制和技术支持,同时还提供培训人员。巴西统一卫生系统采用了国家疟疾消除计划,该计划提供免费诊断和治疗,采取分散行动进行诊断和广泛覆盖治疗,并采用在线信息系统、多部门伙伴关系和研究网络。 2019年10月30日,葛兰素史克巴西公司和MMV宣布,巴西卫生监管局(AVINSA)已批准单剂量他非诺喹上市许可,用于治疗16岁及以上正在接受氯喹治疗的急性间日疟原虫疟疾感染患者。葛兰素史克巴西制药部门总裁Jose Carlos Felner表示,他非诺喹在巴西获批是抗击疟疾等被忽视疾病的重要一步。新型抗疟药物的推出增加了巴西对疟疾治疗的需求,从而帮助当局实现根除疟疾的目标。

南美和中美疟疾治疗市场收入及2030年预测(百万美元)

南美和中美疟疾治疗市场细分

南美和中美疟疾治疗市场根据治疗、给药途径、分销渠道和国家进行细分。根据治疗方法,南美和中美疟疾治疗市场细分为仿制药、原研药、疫苗和其他。疫苗部分在 2022 年占据了最大的市场份额。

就给药途径而言,南美和中美疟疾治疗市场分为口服和肠外给药。口服部分在 2022 年占据了更大的市场份额。

按分销渠道,南美和中美疟疾治疗市场细分为直接招标、医院药房、零售药房、在线药房和其他。直接招标部分在 2022 年占据了最大的市场份额。

根据国家/地区,南美和中美疟疾治疗市场细分为巴西、阿根廷和南美和中美洲其他地区。 2022 年,巴西占据了南美和中美疟疾治疗市场的主导份额。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc 和 Lupin Ltd 是南美和中美疟疾治疗市场的一些领先企业。

South & Central America Malaria Treatment Strategic Insights

Strategic insights for South & Central America Malaria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-malaria-treatment-market-strategic-framework.webp
Get more information on this report

South & Central America Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 59.68 Million
Market Size by 2030 US$ 247.33 Million
Global CAGR (2022 - 2030) 19.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 治疗
  • 仿制药
  • 原创药物
  • 疫苗
By 给药途径
  • 口服
  • 肠胃外
By 分销渠道
  • 直接招标
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Get more information on this report

    South & Central America Malaria Treatment Regional Insights

    The regional scope of South & Central America Malaria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-malaria-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Malaria Treatment Market

    1. Cipla Ltd
    2. Sun Pharmaceutical Industries Ltd
    3. Sanofi SA
    4. GSK Plc
    5. Novartis AG
    6. Pfizer Inc
    7. Lupin Ltd

    Frequently Asked Questions
    How big is the South & Central America Malaria Treatment Market?

    The South & Central America Malaria Treatment Market is valued at US$ 59.68 Million in 2022, it is projected to reach US$ 247.33 Million by 2030.

    What is the CAGR for South & Central America Malaria Treatment Market by (2022 - 2030)?

    As per our report South & Central America Malaria Treatment Market, the market size is valued at US$ 59.68 Million in 2022, projecting it to reach US$ 247.33 Million by 2030. This translates to a CAGR of approximately 19.4% during the forecast period.

    What segments are covered in this report?

    The South & Central America Malaria Treatment Market report typically cover these key segments-

  • 治疗 (仿制药, 原创药物, 疫苗)
  • 给药途径 (口服, 肠胃外)
  • 分销渠道 (直接招标, 医院药房, 零售药房, 网上药房)
  • What is the historic period, base year, and forecast period taken for South & Central America Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Malaria Treatment Market?

    The South & Central America Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Who should buy this report?

    The South & Central America Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.